Telix Pharmaceuticals US INC
Telix is a biopharmaceutical company that develops and commercialises therapeutic and diagnostic radiopharmaceuticals, which use targeted radiation to inform treatment decisions and deliver personalised therapy. The company's pipeline focuses on urologic oncology (prostate and kidney cancer), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning, supported by a global supply, manufacturing and distribution network. Telix has received regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the U.S. Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent.
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Telix Pharmaceuticals US INC | Fishers | IN | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.